Search Results for "biocon-biochemical"

Deal Boost for Biocon

The firm is looking at partnerships with global pharma majors as a ticket to hasten the launch of its biotech products

Biocon, Syngene looking at overseas listing

BySourav Majumdar,Aveek Datta

R&D Investments Paying Off for Biocon

Biocon: A biosimilar shot in the arm

ByHarichandan Arakali

Biocon strikes partnership with Sandoz to tap biosimilars opportunity

ByHarichandan Arakali

Biocon gets crucial recommendation for biosimilar Trastuzumab in US

Can Biocon Join The $1-billion Club By 2018?

ByDeepti Chaudhary

Biocon-Pfizer Breakup: Why Diabetes Alliances Don't Work for Indian pharma?

World's biggest COVID-19 Vaccine study begins in US; Biocon drug rejected

US FDA win for Biocon raises hopes for other Indian pharma companies

ByHarichandan Arakali

Tech5: Indian space startups to get Rs1,000 crore from Government of India; Biocon Biologics refinances $1.1 billion, and more

ByHarichandan Arakali

Biocon Biologics in Covid-19 antibody deal; Byju's mopping up smaller rivals; the promise of India's SaaS companies

ByHarichandan Arakali

Biocon buys Viatris biosimilars unit for $3.34 bln; Infosys launches 'Metaverse Foundry'; Prime closes Fund IV at $120 mln

ByHarichandan Arakali

Home

/

Search

Latest News

Advertisement

Advertisement

On Everyone’s Radar

Advertisement